A 4-year-old girl developed severe hepatitis following the fourth administration of haJothane in a period of 5 months She was shown to have a circulating antibody which acted specifically against rabbit hepatocytes previously sensitized to halothane. The patient made a full recovery from the hepatitis, but 5 months later, developed diabetes melhtus Halothane is metabolized in humans via at least two pathways, oxidation and reduction, and both have been shown in experiments to be associated with the production of chemically reactive metabolites. McLain, Sipes and Brown (1979) have demonstrated in animals that halothane may be directly toxic to the liver where there is stimulation of the reductive pathway, whereas Davis and colleagues (1980) have evidence that the antigen of the halothane-altered membrane is produced only when the oxidative pathway is activated.
Halothane is metabolized in humans via at least two pathways, oxidation and reduction, and both have been shown in experiments to be associated with the production of chemically reactive metabolites. McLain, Sipes and Brown (1979) have demonstrated in animals that halothane may be directly toxic to the liver where there is stimulation of the reductive pathway, whereas Davis and colleagues (1980) have evidence that the antigen of the halothane-altered membrane is produced only when the oxidative pathway is activated.
In a British Medical Journal Editorial on The Liver and Halothane-Again (Editorial, 1980) it was suggested that a reasonable sequence of causation was: halothane with special factors (hypoxia and enzyme induction) causing enhanced metabolism to produce reactive metabolites with binding to intracellular elements, consequent cell damage, release of transaminases and hepatic cellular necrosis. The important practical lesson from this work is that it draws attention to a group of patients in whom the use of halothane a second time would be theoretically more hazardous. These include patients who are fat, elderly, likely to have enzyme induction, are being stressed with other reactive metabolites (during radiotherapy for example), are undergoing an operation or anaesthetic technique with an appreciable effect on liver blood flow, have an incision or postoperative complication predisposing to hypoxia, and are likely to be still metabolizing a dose of halothane given within the previous 2 weeks. Care in avoiding repeat halothane anaesthetics in these circumstances would probably reduce the already small frequency of this complication even further. According to Davis and others (1980) mild hepatic damage, seen in up to 20% of patients repeatedly anaesthetized with halothane, may be a manifestation of direct toxic injury. If the extremely rare, more severe lesion develops, an additional immune component may be involved.
The actual demonstration of a circulating antibody, in patients with hepatitis, to halothanealtered hepatocytes is credited to Vergani, Mieli-Vergani and co-workers (1978) . Because many of the clinical features of halothane hepatitis suggest an immune-mediated pathogenesis, they studied patients with this condition in a search for circulating antibodies directed against halothanealtered hepatocyte membrane components.
Reports of post-halothane hepatitis in children are extremely rare. In a review of 203 patients with postoperative jaundice (Walton et al., 1976) , two children aged 4 and 5yr were originally included in the series, but a panel of hepatologists were not unanimous about the findings and they were later excluded.
CASE REPORT
A three-year-old girl presented with a history of recurrent urinary tract infections. She was found to have a duplex left kidney with a ureterocele associated with the ureter draining the upper pole which also showed changes suggesting chronic pyelonephritis. Over the next 5 months, she had four general anaesthetics for surgical procedures (two major procedures and two cystoscopic examinations), during which she received halothane (table I) .
For the two cystoscopic examinations pethidine 1 and atropine 0.6 mg premedication were given i.m. 45 min before operation. On both occasions an inhalation technique was used-66% nitrous oxide in oxygen supplemented with halothane up to 2%.
For the major procedures premedication comprised atropine 0.6 mg with morphine 2mg (O.lmgkg" 1 ) for the left heminephrectomy and ureterectomy, and pethidine 25mg (l.Smgkg" 1 ) for the excision of the ureterocele and reimplantation of the left ureter. Premedication was given 45 min before operation. The anaesthetic technique consisted of inhalation induction with 66% nitrous oxide in oxygen supplemented with halothane sufficient to allow tracheal intubation. Neuromuscular blockade was produced with tubocurarine 10 mg.
Ventilation of the lungs was controlled using the same gas mixture supplemented with 0.5% halothane delivered from a Howells Ventilator.
Antagonism of neuromuscular blockade at the end of the procedures was with neostigmine 0.06 mg kg" 1 preceded by atropine 0.02 mg kg" 1 . Forty-eight hours after the final operation the patient became jaundiced. The greatest value of serum bilirubin was 372 umollitre" 1 on the 19th day after operation. The jaundice was hepatocellular in origin, the serum transaminases being dramatically increased (AST 3755 iu litre" 1 , ALT 1438 iu litre" 1 ) on the 2nd day after operation. There was hypoprothrombinaemia and a leucocytosis. Full biochemical and haematological data are presented in table II. Figure 1 shows the efiFect of the hepatocellular damage on the serum bilirubin and alanine aminotransferase (ALT) related to time. At no time during any procedure was there clinical evidence of hypovolaemia, hypotension or hypoxia. The patient did not receive any blood or blood products and tests for hepatitis B antigen were negative. Other virological tests did not yield evidence of recent infection and in particular there was no evidence of hepatitis A antibody. The clinical and biochemical course was not typical of infective hepatitis, the commonest cause of jaundice in childhood.
The patient remained jaundiced for 6 weeks, but improved steadily in that time although, on the 20th day after operation, there was sudden onset of ascites and generalized oedema which cleared with the use of diuretics and spironolactone.
The patient was discharged from hospital on the 35th day after operation with minimal jaundice and was progressing satisfactorily for a time. Five months after her final operation, she was readmitted in diabetic ketoacidosis. At present her blood sugar is controlled with daily insulin and her hepatic and renal functions are satisfactory.
DISCUSSION
This patient developed severe hepatocellular jaundice shortly after the fourth administration of halothane. During the convalescent phase of the illness, the patient's blood was shown to contain an antibody directed specifically against prepared rabbit hepatocytes which had previously been exposed to halothane. This antibody has been found in conjunction with severe halothane-associated hepatitis and does not occur after halothane exposure without liver damage (Vergani, Tsantoulas et al., 1978) . The repeated exposure to halothane at intervals of 4-8 weeks appears to have initiated an antibody response to hepatocytes sensitized to halothane or one of its metabolites.
It could be argued that the exposure of this child to halothane four times in 5 months constitutes clinical imprudence, but if one studies the literature there is very little evidence that such exposure constitutes an unacceptable risk.
We are fully aware of the factors such as hypoxia and hypovolaemia, but there is no clinical evidence that they occurred at any time in this patient. There was no known exposure to other hepatotoxic agents which could have exposed the child to additional risk factors. We believe that the clinical course and investigations show that this child did suffer halothane hepatitis.
Neutrophilia following the fourth administration of halothane may be relevant. An increase in the white blood count to a peak of 32.4 x 10 9 litre" 1 (84% neutrophils) was noted following the second halothane anaesthetic. This is a greater increase than would be expected following major surgery and may, in retrospect, have been significant. The development of diabetes mellitus remains unexplained, but there was a history of this condition in the patient's uncle. We think that the diabetes was coincidental rather than directly related to her illness. 
